Source: PRWeb

Press Release: Shoreline Biome : Shoreline Biome Issued Patent for Cell Lysis and Preparation of High Molecular Weight DNA from Modified Cells

Patent outlines method and materials for the lysis of modified eukaryotic cells(PRWeb November 02, 2021)Read the full story at https://www.prweb.com/releases/shoreline_biome_issued_patent_for_cell_lysis_and_preparation_of_high_molecular_weight_dna_from_modified_cells/prweb18294416.htm

Read full article »

Shoreline Biome's Competitors | Shoreline Biome's News | Shoreline Biome's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Paul Denslow

CEO Approval Rating

90/100

Shoreline Biome is a Connecticut-based biotechnology platform that offers solutions such as microbiome testing and pathogen identification for the healthcare sector.